Louisiana 2020 Regular Session

Louisiana House Bill HB158

Introduced
2/24/20  
Refer
2/24/20  
Refer
2/24/20  
Refer
3/9/20  
Refer
3/9/20  
Report Pass
5/13/20  
Report Pass
5/13/20  
Engrossed
5/21/20  
Engrossed
5/21/20  
Refer
5/22/20  
Refer
5/22/20  
Report Pass
5/27/20  

Caption

Authorizes the recommendation of medical marijuana in treating certain neurodegenerative diseases and conditions

Impact

The bill represents an important legislative step toward improving patient care for those suffering from debilitating neurodegenerative diseases. By allowing medical marijuana as a treatment option, it is expected that patients will have access to alternatives that could potentially ease their suffering and improve their quality of life. Healthcare providers licensed by the Louisiana State Board of Medical Examiners will now be enabled to provide recommendations for these additional conditions, which could lead to widespread changes in how such medical cases are managed in the state.

Summary

House Bill 158 authorizes physicians to recommend medical marijuana for treating a range of neurodegenerative diseases and conditions. Specifically, the bill expands the existing list of debilitating medical conditions for which patients can receive medical marijuana recommendations to include Alzheimer's disease, amyotrophic lateral sclerosis (ALS), Huntington's disease, Lewy body dementia, motor neuron disease, Parkinson's disease, and spinal muscular atrophy. This change reflects a growing recognition of the potential therapeutic benefits of medical marijuana in alleviating symptoms associated with these severe conditions.

Sentiment

The overall sentiment surrounding HB 158 has been largely positive among supporters, particularly from patient advocacy groups and individuals affected by these neurodegenerative conditions. Many view the expansion of medical marijuana use as a necessary advancement in treatment options, especially given the often limited effectiveness of traditional medications for these diseases. However, there may also be segments of the population concerned about the implications of increased medical marijuana access, which could raise questions about regulation and distribution practices.

Contention

Notable points of contention regarding the bill may center around the ongoing debates surrounding medical marijuana legalization more broadly, including concerns about misuse or the potential societal impacts of expanded access. Opponents might argue that while the intention is to help patients, there must be stringent oversight and education on medical marijuana to ensure it is prescribed safely and responsibly. Ensuring that healthcare providers have adequate resources and guidance when making recommendations will be crucial for the successful implementation of HB 158.

Companion Bills

No companion bills found.

Previously Filed As

LA HB704

Establishing the Neurodegenerative Disease Research Program and the Neurodegenerative Disease Research Program Fund; and imposing duties on the Department of Health.

LA SB1525

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

LA SB1047

An act to amend Sections 103871 and 103871.2 of the Health and Safety Code, relating to public health.

LA SB1812

Relating to prior authorization for prescription drug benefits related to the treatment of neurodegenerative diseases.

LA SB778

Qualifying Medical Conditions for Medical Use of Marijuana:

LA SB270

Provides for access to medical marijuana for terminally ill patients in a healthcare facility. (8/1/26)

LA HB1504

Relating to authorizing the possession, use, cultivation, distribution, transportation, and delivery of medical cannabis for medical use by qualifying patients with certain debilitating medical conditions and the licensing of dispensing organizations and cannabis testing facilities; authorizing fees.

LA SB734

Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing a fee.

LA HB460

Provides relative to employment discrimination against certain employees being treated with medical marijuana

LA SB170

Relating to authorizing the possession, use, cultivation, distribution, delivery, sale, and research of medical cannabis for medical use by patients with certain medical conditions and the licensing of medical cannabis organizations; authorizing fees.

Similar Bills

AZ SB1641

marijuana producers; licensure

OK HB2807

Medical marijuana; medical marijuana transporter license; providing issuance of licenses for premises under certain circumstances; directing creation of inventory manifests documenting certain information; allowing certain licensees to maintain and operate warehouses under certain conditions; effective date; emergency.

OK HB2807

Medical marijuana; medical marijuana transporter license; providing issuance of licenses for premises under certain circumstances; directing creation of inventory manifests documenting certain information; allowing certain licensees to maintain and operate warehouses under certain conditions; effective date; emergency.

AZ SB1713

Marijuana; dual licensees; rural communities

OK HB2897

Medical marijuana; transportation license; allowing transport of medical marijuana to patients; warehouses; inventory manifests and logs; signage; effective date.

OK HB2897

Medical marijuana; transportation license; allowing transport of medical marijuana to patients; warehouses; inventory manifests and logs; signage; effective date.